Apollo Endosurgery is a holding company. Through its subsidiaries, Co. is a medical technology company primarily focused on the design, development and commercialization of medical devices to develop gastrointestinal (GI) therapeutic endoscopy. Co.'s products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat various GI conditions including closure of acute perforations and chronic fistulas; inadvertent perforation of the GI tract; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; the treatment of swallowing disorders (peroral endoscopic myotomy); esophageal stent fixation and obesity. We show 26 historical shares outstanding datapoints in our coverage of APEN's shares outstanding history.
Understanding the changing numbers of APEN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like APEN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching APEN by allowing them to research APEN shares outstanding history
as well as any other stock in our coverage universe. |
Free APEN Email Alerts:
Video: Shares Outstanding Importance
